FDA — authorised 26 October 2001
- Application: NDA021356
- Marketing authorisation holder: GILEAD SCIENCES INC
- Local brand name: VIREAD
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Tenofovir DF in United States
FDA authorised Tenofovir DF on 26 October 2001
Marketing authorisations
FDA — authorised 18 January 2012
- Application: NDA022577
- Marketing authorisation holder: GILEAD SCIENCES INC
- Local brand name: VIREAD
- Indication: POWDER — ORAL
- Status: approved
FDA
- Status: approved
Tenofovir DF in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Tenofovir DF approved in United States?
Yes. FDA authorised it on 26 October 2001; FDA authorised it on 18 January 2012; FDA has authorised it.
Who is the marketing authorisation holder for Tenofovir DF in United States?
GILEAD SCIENCES INC holds the US marketing authorisation.